Invesco PRFZ ETF analysis: fundamentally weighted small/mid-cap exposure, strong 3- & 5-year results, low concentration risk.

Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactamFosmanogepix second phase 3 study initiated; two phase 3 studies in invasive fungal infecti ...

Markets are shifting from easy gains to a new regime where earnings and execution matter. Read the full analysis here.

Detailed price information for Fair Isaac and Company (FICO-N) from The Globe and Mail including charting and trades.

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infectives ...

Equity investors on the Nigerian Exchange recorded an estimated N410 billion gain on Wednesday as strong performances from ...

WOOD DALE, Ill., Jan. 6, 2026 /PRNewswire/ -- (NYSE: AIR), a leading provider of aviation services to commercial and ...

Thank you, Matthew, and hello, everyone, and thank you for joining us to review CSPi's financial results for the fiscal 2025 ...

Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactamFosmanogepix ...

One bettor's big win on Nicolás Maduro's surprise ousting puts the spotlight on geopolitical events contracts.

Learn how credit card posting affects your transaction timeline, the differences between transaction and post dates, and how it impacts your account balance and payments.

Microsoft's default settings for Windows 11 are filled with tiny annoyances, including unnecessary taskbar icons and unwanted apps. Here's how to declutter your new setup and maximize your security ...